Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Mechanical Stabilization of the Glandular Acinus by Linker of Nucleoskeleton and Cytoskeleton Complex.

Zhang Q, Narayanan V, Mui KL, O'Bryan CS, Anderson RH, Kc B, Cabe JI, Denis KB, Antoku S, Roux KJ, Dickinson RB, Angelini TE, Gundersen GG, Conway DE, Lele TP.

Curr Biol. 2019 Sep 9;29(17):2826-2839.e4. doi: 10.1016/j.cub.2019.07.021. Epub 2019 Aug 8.

PMID:
31402305
2.

N-cadherin adhesive interactions modulate matrix mechanosensing and fate commitment of mesenchymal stem cells.

Cosgrove BD, Mui KL, Driscoll TP, Caliari SR, Mehta KD, Assoian RK, Burdick JA, Mauck RL.

Nat Mater. 2016 Dec;15(12):1297-1306. doi: 10.1038/nmat4725. Epub 2016 Aug 15.

3.

The mechanical regulation of integrin-cadherin crosstalk organizes cells, signaling and forces.

Mui KL, Chen CS, Assoian RK.

J Cell Sci. 2016 Mar 15;129(6):1093-100. doi: 10.1242/jcs.183699. Epub 2016 Feb 26. Review.

4.

Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2.

Hsu BY, Bae YH, Mui KL, Liu SL, Assoian RK.

PLoS One. 2015 Jun 11;10(6):e0128974. doi: 10.1371/journal.pone.0128974. eCollection 2015.

5.

N-Cadherin Induction by ECM Stiffness and FAK Overrides the Spreading Requirement for Proliferation of Vascular Smooth Muscle Cells.

Mui KL, Bae YH, Gao L, Liu SL, Xu T, Radice GL, Chen CS, Assoian RK.

Cell Rep. 2015 Mar 10;10(9):1477-1486. doi: 10.1016/j.celrep.2015.02.023. Epub 2015 Mar 5.

6.

A FAK-Cas-Rac-lamellipodin signaling module transduces extracellular matrix stiffness into mechanosensitive cell cycling.

Bae YH, Mui KL, Hsu BY, Liu SL, Cretu A, Razinia Z, Xu T, Puré E, Assoian RK.

Sci Signal. 2014 Jun 17;7(330):ra57. doi: 10.1126/scisignal.2004838.

7.

The effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.

Romero IL, Lee W, Mitra AK, Gordon IO, Zhao Y, Leonhardt P, Penicka CV, Mui KL, Krausz TN, Greene GL, Lengyel E.

Gynecol Oncol. 2012 Jan;124(1):134-41. doi: 10.1016/j.ygyno.2011.08.026. Epub 2011 Oct 11.

8.

Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.

Romero IL, Gordon IO, Jagadeeswaran S, Mui KL, Lee WS, Dinulescu DM, Krausz TN, Kim HH, Gilliam ML, Lengyel E.

Cancer Prev Res (Phila). 2009 Sep;2(9):792-9. doi: 10.1158/1940-6207.CAPR-08-0236. Epub 2009 Sep 8.

9.

Regulation of gonadotropin-releasing hormone in nonhypothalamic tissues.

Kim HH, Mui KL, Nikrodhanond AA, Tamayo NC.

Semin Reprod Med. 2007 Sep;25(5):326-36. Review.

PMID:
17710728

Supplemental Content

Support Center